GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
CJC-1295 with DAC 10mg

CJC-1295 with DAC 10mg

CJC-1295 DAC

CAS: 863288-34-0

$89.99$99.9910% OFFIn Stock

CJC-1295 with DAC (Drug Affinity Complex) features a maleimidopropionic acid modification enabling covalent thioether bonding to serum albumin. This extends the half-life to 6-8 days — the same DAC technology as in our CJC-1295/Ipamorelin blend. 99.0% HPLC purity.

Specifications

Vial Size10mg
FormLyophilized Powder
Purity99.0% HPLC
CAS863288-34-0
Storage-20C long-term
Shop This Compound

For laboratory research use only. Not for human consumption.

Mechanism of Action

GHRH receptor agonist with sustained albumin binding producing a continuous elevation of GH pulse amplitude over the 6-8 day dosing window without disrupting natural pulsatility architecture.

Research FAQ

Does CJC-1295 with DAC suppress natural GH pulses?

No. The sustained GHRH receptor activation amplifies pulse amplitude but does not override the somatostatin-mediated pulse inhibition. Natural pulsatility is preserved.

Related Compounds